The fact that intestinal metaplasia (IM) is a common finding in both benign and
malignant conditions and that its incidence increases with age, limits its potential value as an indicator
of gastric cancer risk.
In this chapter we focus on the heterogeneity of IM as shown by morphological parameters of cell
differentiation, crypt architecture and mucin histochemistry.
The importance of these classifications is based on retrospective and prospective studies in different
populations which indicate a close association between certain subtypes of IM and the risk of gastric
carcinoma.
Method | Colour | Mucins |
---|---|---|
Diastase Periodic Schiff (D-PAS) |
Magenta | - Neutral mucins and acid mucins - Some non-sulphated acid mucins (sialomucins) |
Periodate-Borohydride /Saponification/PAS (PB/KOH/PAS) |
Magenta | O-Acylated Borohydride/sialomucins |
Alcian blue pH 2,5/PAS |
Blue Magenta Purple-blue |
- Acid mucins - Neutral mucins - Mixed neutral and acid mucins |
High iron diamine/ Alcian blue pH 2,5 (HID/AB) |
Brown Blue |
- Sulphomucins - Non-sulphated acid mucins (sialomucins) |
GASTROINTESTINAL MUCINS AND AGE
Throughout foetal life, gastric surface mucus is a mixture of sialomucins and neutral mucins with a gradual decrease of sialomucins and neutral mucins being predominant at 23 weeks, reaching an adult pattern at birth. O-acylated mucins and sulphomucins are not detected.
In the adult most of the gastrointestinal mucins contain sialic acid residues and sulphate groups, which may be present in the same glycoprotein molecule but in different oligosaccharide units.
VARIOUS CLASSIFICATIONS OF INTESTINAL METAPLASIA
Based on Mucin Histochemistry/Morphology/Differentiation Staining Techniques : (Alcian Blue/PAS and
HID/AB)
•1A – Intestinal Metaplasia
HID/AB Staining : Blue = sialomucins; Brown = sulphomucins.
Considering that the presence of sulphomucins is the main characteristic of IM type 3, the relative risk
of gastric carcinoma was estimated according to the presence of sulphomucins in "intermediate columnar
cells", in goblet cells and other cells (basal, neck region or foveolar).
IM types 1 and 2 : were subdivided with two groups :
Classification of intestinal metaplasia based on sialomucin acetylation sites (SAS)
In normal circumstances O-acylated sialic acids are secreted only in the epithelial cells of the lower Gl tract (ie caecum, colon or rectum) and not in the small intestine.
• Complete IM (type 1) :
Characterised by columnar cells (non-mucin-secreting) and goblet cells which often show strong dPAS
positivity. Only a few are weakly positive and these show strong positivity with PB/KOH/PAS indicating
O-acylated sialomucins. With HID/AB these goblet cells show predominance of sialomucins and occasional
focal sulphomucins.
Thus complete IM resembles small intestine, thus sialomucins predominate including N-acetyl sialomucins,
less amount of O-acylated sialomucins and rarely sulphomucins.
• Incomplete IM (type 2 or 3) :
Characterised by columnar mucous-secreting cells and goblet cells resembling colonic mucosa. Unlike
complete IM no PB/KOH/PAS positive mucin was detected in the columnar cells or goblet cells in either type
2 or type 3 IM. This pattern is normally found in fetal gut, suggesting that O-acylation loss in incomplete
IM may be related to a more immature type of epithelium similar to that found in fetal gut where
O-acetylation has not yet taken place. It has also been interpreted as a phenotypic change related to one
hostile microenvironment, impaired maturation or aberrant differentiation along ileal and colonic cell
lines.
INTESTINAL MUCIN TYPES AND CLINICAL IMPLICATIONS
The relationship between gastric carcinoma and intestinal metaplasia of "incomplete type", "colonic type", type 3 showing incomplete differentiation and the presence of columnar cells and goblet cells secreting sulphomucins, has been assessed in various populations.
In a large cohort study it was shown that type 3 IM is closely associated with gastric carcinoma of intestinal type, and within IM it is a more selective indicator of cancer risk. Types I and II are prevalent in both benign and malignant conditions, and are thus not useful as markers of cancer risk.